Ten Medical Devices Enter Innovation Channel: Breakthroughs Across Multiple Technology Tracks

Products Proposed for the Innovation Channel

The products proposed to enter the innovation channel include:

●Urethral bulking agent; applicant: Chengdu Chipu Biotechnology Co., Ltd.

●Additive manufactured PEEK patient-matched sternum and rib prosthesis; applicant: Dimension (Xi'an) Biomedical Technology Co., Ltd.

●Drug-eluting peripheral arterial stent system; applicant: Shanghai Hongmai Medical Technology Co., Ltd.

●Shoulder arthroplasty surgical navigation and positioning system; applicant: Beijing Estun Medical Technology Co., Ltd.

●Non-small cell lung cancer drug sensitivity test kit (in vitro cell culture method); applicant: Beijing Genecast Medical Laboratory Co., Ltd.

●Upper gastrointestinal electronic endoscopic surgery control system; applicant: Shanghai Aohua Endoscopy Co., Ltd.

●3D-printed tissue engineering scaffold for breast reconstruction; applicant: Shenzhen Breje Biotechnology Co., Ltd.

●Microsurgical operation control system; applicant: Ontai Microfine Medical Technology (Shanghai) Co., Ltd.

●Chest CT image-assisted diagnosis software; applicant: Shanghai United Imaging Intelligence Co., Ltd.

●Intracranial deep electrode; applicant: Beijing Zhiren Medical Technology Co., Ltd.

Multi-track Technology Breakthroughs

This batch includes products across artificial intelligence-assisted diagnosis, surgical robotics, 3D-printed implants, and brain-computer interface related technologies.

The selection reflects that China's medical device innovation is moving from isolated breakthroughs toward integrated development across multiple technology platforms.

The inclusion of chest CT image-assisted diagnosis software has also renewed industry attention on the development of medical AI.